These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 14610223

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. RNA interference in the mouse vascular endothelium by systemic administration of siRNA-lipoplexes for cancer therapy.
    Santel A, Aleku M, Keil O, Endruschat J, Esche V, Durieux B, Löffler K, Fechtner M, Röhl T, Fisch G, Dames S, Arnold W, Giese K, Klippel A, Kaufmann J.
    Gene Ther; 2006 Sep; 13(18):1360-70. PubMed ID: 16625242
    [Abstract] [Full Text] [Related]

  • 44. Suppression of EGFR expression by antisense or small interference RNA inhibits U251 glioma cell growth in vitro and in vivo.
    Kang CS, Zhang ZY, Jia ZF, Wang GX, Qiu MZ, Zhou HX, Yu SZ, Chang J, Jiang H, Pu PY.
    Cancer Gene Ther; 2006 May; 13(5):530-8. PubMed ID: 16410821
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Selection and validation of optimal siRNA target sites for RNAi-mediated gene silencing.
    Luo Q, Kang Q, Song WX, Luu HH, Luo X, An N, Luo J, Deng ZL, Jiang W, Yin H, Chen J, Sharff KA, Tang N, Bennett E, Haydon RC, He TC.
    Gene; 2007 Jun 15; 395(1-2):160-9. PubMed ID: 17449199
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Lipidic carriers of siRNA: differences in the formulation, cellular uptake, and delivery with plasmid DNA.
    Spagnou S, Miller AD, Keller M.
    Biochemistry; 2004 Oct 26; 43(42):13348-56. PubMed ID: 15491141
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Vectors for RNA interference.
    Wadhwa R, Kaul SC, Miyagishi M, Taira K.
    Curr Opin Mol Ther; 2004 Aug 26; 6(4):367-72. PubMed ID: 15468595
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. The impact of polyadenylation signals on plasmid nuclease-resistance and transgene expression.
    Azzoni AR, Ribeiro SC, Monteiro GA, Prazeres DM.
    J Gene Med; 2007 May 26; 9(5):392-402. PubMed ID: 17407167
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Efficient delivery of siRNA for inhibition of gene expression in postnatal mice.
    Lewis DL, Hagstrom JE, Loomis AG, Wolff JA, Herweijer H.
    Nat Genet; 2002 Sep 26; 32(1):107-8. PubMed ID: 12145662
    [Abstract] [Full Text] [Related]

  • 58. RNA-induced silencing complex-bound small interfering RNA is a determinant of RNA interference-mediated gene silencing in mice.
    Wei J, Jones J, Kang J, Card A, Krimm M, Hancock P, Pei Y, Ason B, Payson E, Dubinina N, Cancilla M, Stroh M, Burchard J, Sachs AB, Hochman JH, Flanagan WM, Kuklin NA.
    Mol Pharmacol; 2011 Jun 26; 79(6):953-63. PubMed ID: 21427169
    [Abstract] [Full Text] [Related]

  • 59. Prolonged in vivo gene silencing by electroporation-mediated plasmid delivery of small interfering RNA.
    Eefting D, Grimbergen JM, de Vries MR, van Weel V, Kaijzel EL, Que I, Moon RT, Löwik CW, van Bockel JH, Quax PH.
    Hum Gene Ther; 2007 Sep 26; 18(9):861-9. PubMed ID: 17850190
    [Abstract] [Full Text] [Related]

  • 60. Persistent interferon transgene expression by RNA interference-mediated silencing of interferon receptors.
    Takahashi Y, Vikman E, Nishikawa M, Ando M, Watanabe Y, Takakura Y.
    J Gene Med; 2010 Sep 26; 12(9):739-46. PubMed ID: 20821744
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.